Imunoglukan Information

Founded in 2000, Pleuran, s.r.o. has over 20 years of proprietary R&D history possessing a rich portfolio of evidence based medicine on its proprietary 100% natural beta-glucan isolate ranging from elementary in-vitro and animal studies to advanced degree of double-blind, placebo controlled, randomized clinical studies. Imunoglukan, s.r.o. was later founded in 2010. Today it serves as the commercial arm of the business, currently selling over one million units annually and covering 16 markets with leading positions in Czech Republic and Slovakia. Imunoglukan recorded average sales growth of over 20% annually since 2010. The company launched its first product Imunoglukan P4H ® in 2001 in capsule form, followed by the development of the today patented dietary and cosmetic hydrogel. The company consequently formulated the Imunoglukan P4H ® syrup which is the landmark product of the company. The company has further marketed other successful product extensions such as the Imunoglukan P4H ® cream (wide spectrum topical product), Imunoglukan P4H ® ACUTE! (5 capsules, high dose package for acute needs) or the Imunoglukan P4H ® SynBIO product extension (Imunoglukan and probiotics fusion preparation) providing additional benefits for the digestive tract. Imunoglukan is currently in the process of developing methods of application of its natural bioactive ingredient in other food & health care fields within human and veterinary sectors.